To determine the putative contribution of ADAM17 to the release of endogenous ephrin-A1 from the cell surface of tumor cells, we analyzed the supernatant of ADAM17 inhibited cells (TMI-005 or MEDI3622 treated) and compared it to their untreated controls. The gene discussed is ADAM17; the disease is neoplasm.